Advocacy at a Glance 5/28/21 Advocacy at a Glance 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More Analysis and Commentary 5/21/21 Analysis and Commentary 5/21/21 Messaging for Upcoming Senate Hill Days Read More Advocacy at a Glance 5/21/21 Advocacy at a Glance 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Advocacy at a Glance 5/16/21 Advocacy at a Glance 5/16/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Advocacy at a Glance 5/8/21 Advocacy at a Glance 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 Key Take-Aways from Hill Day (Part One) Read More Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More Analysis and Commentary 4/23/21 Analysis and Commentary 4/23/21 Alliance "Hill Day": April 28 and 29 Read More Advocacy at a Glance 4/16/21 Advocacy at a Glance 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More Advocacy at a Glance 3/19/20 Advocacy at a Glance 3/19/20 Advocacy at a Glance Read More Advocacy at a Glance 3/13/20 Advocacy at a Glance 3/13/20 Advocacy at a Glance Read More Analysis and Commentary 3/5/20 Analysis and Commentary 3/5/20 Additional funding for FDA; more Qs and As Read More Advocacy at a Glance 3/5/20 Advocacy at a Glance 3/5/20 Advocacy at a Glance Read More Analysis and Commentary 2/27/20 Analysis and Commentary 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More Advocacy at a Glance 2/28/20 Advocacy at a Glance 2/28/20 Advocacy at a Glance Read More Advocacy at a Glance 2/21/20 Advocacy at a Glance 2/21/20 Advocacy at a Glance Read More Analysis and Commentary 2/1/20 Analysis and Commentary 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More Advocacy at a Glance 2/1/20 Advocacy at a Glance 2/1/20 Advocacy at a Glance Read More Analysis and Commentary 1/17/20 Analysis and Commentary 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More Advocacy at a Glance 1/10/20 Advocacy at a Glance 1/10/20 Advocacy at a Glance Read More Older Posts
Advocacy at a Glance 5/28/21 Advocacy at a Glance 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More
Analysis and Commentary 5/21/21 Analysis and Commentary 5/21/21 Messaging for Upcoming Senate Hill Days Read More
Advocacy at a Glance 5/21/21 Advocacy at a Glance 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
Advocacy at a Glance 5/16/21 Advocacy at a Glance 5/16/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
Advocacy at a Glance 5/8/21 Advocacy at a Glance 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More
Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 Key Take-Aways from Hill Day (Part One) Read More
Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More
Analysis and Commentary 4/23/21 Analysis and Commentary 4/23/21 Alliance "Hill Day": April 28 and 29 Read More
Advocacy at a Glance 4/16/21 Advocacy at a Glance 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More
Analysis and Commentary 3/5/20 Analysis and Commentary 3/5/20 Additional funding for FDA; more Qs and As Read More
Analysis and Commentary 2/27/20 Analysis and Commentary 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More
Analysis and Commentary 2/1/20 Analysis and Commentary 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More
Analysis and Commentary 1/17/20 Analysis and Commentary 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More
